3 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 3 |
Follow CAR: new trials by email Literature Review of CAR trials Research Report on CAR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia TAA05 cell injection - CAR, Acute Myeloid Leukemia | Not applicable | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 5 | 2021-07-01 | 2021-11-04 |
| TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia Chimeric antigen receptor T cells (car-t) - CAR, Acute Myeloid Leukemia | Not applicable | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 5 | 2019-12-09 | 2021-03-08 |
| CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors Targeting CD276 autologous chimeric antigen receptor T cells - CAR, Solid Tumor | Not applicable | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 5 | 2019-09-01 | 2020-12-31 |
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. (3)
China (3)
Xingbing Wang (2)